Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 8
Submit an article Journal homepage
501
Views
18
CrossRef citations to date
0
Altmetric
Review

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

Victoria MandilarasDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, CanadaView further author information
,
Mégane VernonINSERM U1086 “ANTICIPE” (Interdisciplinary Research Unit for Cancers Prevention and Treatment, Axis BioTICLA “Biology and Innovative Therapeutics for Ovarian Cancers”), Normandie Univ, UNICAEN, Caen, France;Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, FranceView further author information
,
Matthieu Meryet-FiguièreINSERM U1086 “ANTICIPE” (Interdisciplinary Research Unit for Cancers Prevention and Treatment, Axis BioTICLA “Biology and Innovative Therapeutics for Ovarian Cancers”), Normandie Univ, UNICAEN, Caen, France;Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, FranceView further author information
,
Katherine KarakasisDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, CanadaView further author information
,
Bernard LambertINSERM U1086 “ANTICIPE” (Interdisciplinary Research Unit for Cancers Prevention and Treatment, Axis BioTICLA “Biology and Innovative Therapeutics for Ovarian Cancers”), Normandie Univ, UNICAEN, Caen, France;Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France;Délégation régionale de Normandie, CNRS, Caen, FranceView further author information
,
Laurent PoulainINSERM U1086 “ANTICIPE” (Interdisciplinary Research Unit for Cancers Prevention and Treatment, Axis BioTICLA “Biology and Innovative Therapeutics for Ovarian Cancers”), Normandie Univ, UNICAEN, Caen, France;Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, FranceView further author information
,
Amit OzaDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, CanadaView further author information
,
Christophe DenoyelleINSERM U1086 “ANTICIPE” (Interdisciplinary Research Unit for Cancers Prevention and Treatment, Axis BioTICLA “Biology and Innovative Therapeutics for Ovarian Cancers”), Normandie Univ, UNICAEN, Caen, France;Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, FranceView further author information
&
Stephanie LheureuxDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, CanadaCorrespondence[email protected]
View further author information
 show all
Pages 927-943 | Received 22 Feb 2017, Accepted 07 Jun 2017, Published online: 22 Jun 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.